Effect of direct-to-consumer genomewide profiling to assess disease risk.
about
Phased whole-genome genetic risk in a family quartet using a major allele reference sequencePersonal genome testing in medical education: student experiences with genotyping in the classroomUsers' motivations to purchase direct-to-consumer genome-wide testing: an exploratory study of personal storiesThe impact of communicating genetic risks of disease on risk-reducing health behaviour: systematic review with meta-analysisInternet-Based Direct-to-Consumer Genetic Testing: A Systematic ReviewExploring predisposition and treatment response--the promise of genomicsAnnotating individual human genomesUse of contemporary genetics in cardiovascular diagnosisGenetic risk prediction in complex diseaseParticipant use and communication of findings from exome sequencing: a mixed-methods study.Research Conducted Using Data Obtained through Online Communities: Ethical Implications of Methodological LimitationsBeyond base pairs to bedside: a population perspective on how genomics can improve healthEvidence for the role of EPHX2 gene variants in anorexia nervosaA chasm of misunderstanding: The widening gap between public perception and scientific consensusAutobiologies on YouTube: Narratives of Direct-to-Consumer Genetic TestingReflections on the cost of "low-cost" whole genome sequencing: framing the health policy debateOpen sharing of genomic data: Who does it and why?The effect of communicating the genetic risk of cardiometabolic disorders on motivation and actual engagement in preventative lifestyle modification and clinical outcome: a systematic review and meta-analysis of randomised controlled trials.Genetic Testing Awareness and Attitudes among Latinos: Exploring Shared Perceptions and Gender-Based DifferencesIncorporating a Genetic Risk Score Into Coronary Heart Disease Risk Estimates: Effect on Low-Density Lipoprotein Cholesterol Levels (the MI-GENES Clinical Trial)Psychological and behavioural impact of returning personal results from whole-genome sequencing: the HealthSeq projectIncorporation of personal single nucleotide polymorphism (SNP) data into a national level electronic health record for disease risk assessment, part 1: an overview of requirements.Anticipation of Personal Genomics Data Enhances Interest and Learning Environment in Genomics and Molecular Biology Undergraduate CoursesEffects of undergoing multiplex genetic susceptibility testing on parent attitudes towards testing their children.Diet and exercise changes following direct-to-consumer personal genomic testing.Public trust in genomic risk assessment for type 2 diabetes mellitus.Managing Expectational Language: Translational genetic professionals consider the clinical potential of next-generation sequencing technologies.Design and implementation of a randomized controlled trial of genomic counseling for patients with chronic disease.Susceptibility to type 2 diabetes mellitus--from genes to preventionGenetics patients' perspectives on clinical genomic testing.Does personal genome testing drive service utilization in an adult preventive medicine clinic?Teaching genomic counseling: preparing the genetic counseling workforce for the genomic eraPersonal genome testing: test characteristics to clarify the discourse on ethical, legal and societal issuesGenomic Analysis as the First Step toward Personalized Treatment in Renal Cell CarcinomaPhysical activity attenuates the influence of FTO variants on obesity risk: a meta-analysis of 218,166 adults and 19,268 children.The role of disease characteristics in the ethical debate on personal genome testing.Implementation and utilization of genetic testing in personalized medicine.Growing up in the genomic era: implications of whole-genome sequencing for children, families, and pediatric practice.Striking a balance in communicating pharmacogenetic test results: promoting comprehension and minimizing adverse psychological and behavioral responseSocial and behavioral research in genomic sequencing: approaches from the Clinical Sequencing Exploratory Research Consortium Outcomes and Measures Working Group.
P2860
Q21144940-BE8D8153-A154-4F0B-86C8-DBF2EE68FFFCQ21183965-B695C7F7-B64B-4B39-8835-31499C3A2CCBQ24635266-0565BA5F-D1C5-4B77-AB18-77579F7EE1B0Q26765401-07A94E51-9A4E-4571-AD70-9C5B69EB320EQ26775070-A357EE1D-DE4B-41A6-BE3A-7B0A609D354DQ26851609-20B576C7-83E8-4DF0-9691-41B05AC07BBEQ26999723-25EDE4C2-8DA6-4F32-8C97-8EACE56FB153Q27025306-A6FF8D88-796A-4687-B082-F423183B24BDQ27027720-31D5000E-D29C-40A2-8940-869E618D7166Q27324155-4C0CE5CA-80F3-49E5-8596-48E162E3F472Q27826359-877695E5-DD41-425D-B465-18D91E820C7FQ28390595-506AFB7F-2CBA-436F-8C00-86CAA45DACD7Q28392332-0EF7C3C5-C105-46C9-80F4-7563736508E9Q28654708-AA836B17-FBB6-4259-A389-8E02703C8ADAQ28658484-1F6AD9CC-E6CC-481E-91B0-A2D9D9024288Q28661760-35F92578-AE1C-464A-B0B3-6C917D8000F6Q29896620-9E63FB81-1EA1-4F8B-9333-A778D5886253Q30249029-11B49D49-F51B-4183-A1C5-22A3CE416E3CQ30696780-43B991EA-DAB0-4F8F-A078-D09816C465E9Q30731532-54D67AC1-6878-4806-9E98-771596E5EBFBQ30839097-97BA6B5B-2F7D-4428-8C75-F637E9A7C6E1Q30884931-55C9C0F2-781E-4AE6-8AB1-C8BC3590BBBFQ30985098-EE2F83F9-9D2B-4A5B-B023-426FECB4B617Q33560771-793F49BD-88AF-4B03-A3CD-6AA7DD88BFF5Q33623616-E87A2380-D8A6-4E7D-83CD-87D6B9C73D19Q33638867-B1963F63-D2AD-482B-B0D2-872576C3F6BCQ33686458-0BDC8624-70CD-455C-B031-CC28BE6E0C30Q33732477-FAAC14AE-6CE5-451E-923D-98A591AEE29FQ33759253-CFC43CAE-7164-46C3-B097-6D6EE4CC9C4FQ33771605-AFC72833-5F9F-4E71-AE8F-0277C9D834E5Q33870450-94EFB256-D885-4B54-904A-6EDA8CB12AA2Q33894105-FAECE47E-785F-4471-993A-EFA313892755Q33932189-483A78F6-CBF3-48C4-B489-2BF993F721B3Q33947929-7BE26329-917D-49AC-AEB3-A0F870C14452Q34070466-F1FB502D-55DD-42CF-9C05-B9CE3D4FFD4AQ34133195-10AEBC2D-8A64-4864-99B6-CA9F57A619B9Q34147916-10841EE6-AF30-45A0-A466-98F7B2E6BCF4Q34157264-27F1BCE9-D19D-4E91-A99F-8DC76D08FAAFQ34173696-D13C4BC4-FD9E-4D53-BABD-C07A2F4D01C6Q34175545-8D4ED684-AF55-4FCD-B0E8-432423AB31FE
P2860
Effect of direct-to-consumer genomewide profiling to assess disease risk.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Effect of direct-to-consumer genomewide profiling to assess disease risk.
@ast
Effect of direct-to-consumer genomewide profiling to assess disease risk.
@en
Effect of direct-to-consumer genomewide profiling to assess disease risk.
@nl
type
label
Effect of direct-to-consumer genomewide profiling to assess disease risk.
@ast
Effect of direct-to-consumer genomewide profiling to assess disease risk.
@en
Effect of direct-to-consumer genomewide profiling to assess disease risk.
@nl
prefLabel
Effect of direct-to-consumer genomewide profiling to assess disease risk.
@ast
Effect of direct-to-consumer genomewide profiling to assess disease risk.
@en
Effect of direct-to-consumer genomewide profiling to assess disease risk.
@nl
P2860
P356
P1476
Effect of direct-to-consumer genomewide profiling to assess disease risk.
@en
P2093
Cinnamon S Bloss
P2860
P304
P356
10.1056/NEJMOA1011893
P407
P577
2011-01-12T00:00:00Z